Literature DB >> 28263966

LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation.

C Zhou1,2,3, C Huang2,3, J Wang3, H Huang2, J Li3, Q Xie2, Y Liu4, J Zhu3, Y Li3, D Zhang3, Q Zhu1, C Huang2,3.   

Abstract

Long noncoding RNAs (lncRNAs) are emerging as key factors in various fundamental cellular biological processes, and many of them are likely to have functional roles in tumorigenesis. Maternally expressed gene 3 (MEG3) is an imprinted gene located at 14q32 that encodes a lncRNA, and the decreased MEG3 expression has been reported in multiple cancer tissues. However, nothing is known about the alteration and role of MEG3 in environmental carcinogen-induced lung tumorigenesis. Our present study, for the first time to the best of our knowledge, discovered that environmental carcinogen nickel exposure led to MEG3 downregulation, consequently initiating c-Jun-mediated PHLPP1 transcriptional inhibition and hypoxia-inducible factor-1α (HIF-1α) protein translation upregulation, in turn resulting in malignant transformation of human bronchial epithelial cells. Mechanistically, MEG3 downregulation was attributed to nickel-induced promoter hypermethylation via elevating DNMT3b expression, whereas PHLPP1 transcriptional inhibition was due to the decreasing interaction of MEG3 with its inhibitory transcription factor c-Jun. Moreover, HIF-1α protein translation was upregulated via activating the Akt/p70S6K/S6 axis resultant from PHLPP1 inhibition in nickel responses. Collectively, we uncover that nickel exposure results in DNMT3b induction and MEG3 promoter hypermethylation and expression inhibition, further reduces its binding to c-Jun and in turn increasing c-Jun inhibition of PHLPP1 transcription, leading to the Akt/p70S6K/S6 axis activation, and HIF-1α protein translation, as well as malignant transformation of human bronchial epithelial cells. Our studies provide a significant insight into understanding the alteration and role of MEG3 in nickel-induced lung tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28263966      PMCID: PMC5525547          DOI: 10.1038/onc.2017.14

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  50 in total

Review 1.  Turning off AKT: PHLPP as a drug target.

Authors:  Alexandra C Newton; Lloyd C Trotman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

Review 2.  AP-1 as a regulator of cell life and death.

Authors:  Eitan Shaulian; Michael Karin
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

3.  DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

Authors:  M Okano; D W Bell; D A Haber; E Li
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

4.  Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.

Authors:  Zhou Xu; Xingruo Zeng; Jiawei Xu; Derek Xu; Jingxia Li; Honglei Jin; Guosong Jiang; Xiaosi Han; Chuanshu Huang
Journal:  Neuro Oncol       Date:  2015-12-17       Impact factor: 12.300

5.  Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation.

Authors:  Pengjun Wang; Zhongqiao Ren; Piyun Sun
Journal:  J Cell Biochem       Date:  2012-06       Impact factor: 4.429

6.  PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.

Authors:  Maria-Magdalena Georgescu
Journal:  Genes Cancer       Date:  2010-12

7.  The requirement of c-Jun N-terminal kinase 2 in regulation of hypoxia-inducing factor-1α mRNA stability.

Authors:  Dongyun Zhang; Jingxia Li; Min Zhang; Guangxun Gao; Zhenghong Zuo; Yonghui Yu; Linda Zhu; Jimin Gao; Chuanshu Huang
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

8.  The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells.

Authors:  Li-Xuan Liu; Wei Deng; Xiao-Tao Zhou; Rui-Pei Chen; Meng-Qi Xiang; Yi-Tian Guo; Ze-Jin Pu; Rui Li; Ge-Fei Wang; Ling-Fei Wu
Journal:  Int J Oncol       Date:  2015-11-18       Impact factor: 5.650

Review 9.  Role and regulation of prolyl hydroxylase domain proteins.

Authors:  G-H Fong; K Takeda
Journal:  Cell Death Differ       Date:  2008-02-15       Impact factor: 15.828

Review 10.  DNA methyltransferases: a novel target for prevention and therapy.

Authors:  Dharmalingam Subramaniam; Ravi Thombre; Animesh Dhar; Shrikant Anant
Journal:  Front Oncol       Date:  2014-05-01       Impact factor: 6.244

View more
  45 in total

1.  Autophagy-mediated Mir6981 degradation exhibits CDKN1B promotion of PHLPP1 protein translation.

Authors:  Minggang Peng; Jingjing Wang; Zhongxian Tian; Dongyun Zhang; Honglei Jin; Claire Liu; Jiawei Xu; Jingxia Li; Xiaohui Hua; Jiheng Xu; Chao Huang; Chuanshu Huang
Journal:  Autophagy       Date:  2019-03-08       Impact factor: 16.016

2.  CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells.

Authors:  Junlan Zhu; Grace Huang; Xiaohui Hua; Yang Li; Huiying Yan; Xun Che; Zhongxian Tian; Huating Liufu; Chao Huang; Jingxia Li; Jiheng Xu; Wei Dai; Haishan Huang; Chuanshu Huang
Journal:  Oncogene       Date:  2019-01-11       Impact factor: 9.867

3.  A novel LncRNA HITT forms a regulatory loop with HIF-1α to modulate angiogenesis and tumor growth.

Authors:  Xingwen Wang; Li Li; Kunming Zhao; Qingyu Lin; Huayi Li; Xuting Xue; Wenjie Ge; Hongjuan He; Dong Liu; Hui Xie; Qiong Wu; Ying Hu
Journal:  Cell Death Differ       Date:  2019-11-07       Impact factor: 15.828

4.  lncRNA SNHG5 is associated with poor prognosis of bladder cancer and promotes bladder cancer cell proliferation through targeting p27.

Authors:  Zhipeng Ma; Senyao Xue; Bi Zeng; Daoxian Qiu
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

5.  lncRNA FAM83H-AS1 is associated with the prognosis of colorectal carcinoma and promotes cell proliferation by targeting the Notch signaling pathway.

Authors:  Song Lu; Wei Dong; Pei Zhao; Zhenjun Liu
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

6.  LncRNA, a novel target biomolecule, is involved in the progression of colorectal cancer.

Authors:  Weihong Sun; Shaoshao Ren; Ran Li; Qingshan Zhang; Haiping Song
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

7.  [Overexpression of lncRNA MEG3 inhibits proliferation and invasion of glioblastoma U251 cells in vitro by suppressing HIF1α expression].

Authors:  Qizhi Luo; Fan Zhang; Wei Li; Fang Wang; Lixiang Wu; Baisheng Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

8.  Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma.

Authors:  Haikang Zhao; Xin Wang; Xiaoyun Feng; Xiaoqiang Li; Li Pan; Jianrong Liu; Fenglu Wang; Zhihai Yuan; Lei Yang; Jun Yu; Rujuan Su; Yuelin Zhang; Lianting Ma
Journal:  J Neurooncol       Date:  2018-10-03       Impact factor: 4.130

Review 9.  Metals and molecular carcinogenesis.

Authors:  Yusha Zhu; Max Costa
Journal:  Carcinogenesis       Date:  2020-09-24       Impact factor: 4.944

10.  [High expression of DNMT3B promotes proliferation and invasion of hepatocellular carcinoma cells via Hippo signaling pathway].

Authors:  Gaohong Dong; Fuliang Qiu; Changan Liu; Hao Wu; Yan Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.